LIAN Yongjun, LI Yunmin. Effect of escitalopram combined with amisulpride in the treatment of elderly patients with depression[J]. Journal of Clinical Medicine in Practice, 2020, 24(9): 27-29. DOI: 10.7619/jcmp.202009008
Citation: LIAN Yongjun, LI Yunmin. Effect of escitalopram combined with amisulpride in the treatment of elderly patients with depression[J]. Journal of Clinical Medicine in Practice, 2020, 24(9): 27-29. DOI: 10.7619/jcmp.202009008

Effect of escitalopram combined with amisulpride in the treatment of elderly patients with depression

More Information
  • Received Date: February 09, 2020
  • Available Online: August 27, 2020
  • Objective To explore the effect of escitalopram combined with amisulpride in the treatment of depression patients aged over 65 years and its impact on negative emotions. Methods The clinical data of 190 patients with depression aged over 65 years who were diagnosed and treated in our hospital was analyzed retrospectively, and they were divided into two groups according to different treatment plans: the patients treated with escitalopram alone were selected as control group(n=95), and those treated with escitalopram combined with amisulpride were selected as study group(n=95). The therapeutic efficacy, changes of negative emotions before and after treatment and the incidence of adverse reactions were statistically analyzed. Results The total effective rate of depression in the study group was higher than that in the control group(97.89% vs. 90.53%, P<0.05); after treatment, the Symptom Checklist 90(SCL-90)scores in the study group and the control group were lower than that before treatment, and was lower in the study group than that of the control group(P<0.05); the incidence of side effects in the study group was lower than that in the control group(4.21% vs. 13. 68%, P<0.05). Conclusion Escitalopram combined with amisulpride in the treatment of depression patients aged over 65 years has significant efficacy, which can effectively eliminate the negative emotions of patients, and has higher safety.
  • 黄敏芳, 刘纪猛, 刘灵江, 等. 文拉法辛和艾司西酞普兰治疗抑郁症的效果及对心率变异性和自主神经功能的影响比较[J]. 中国医药导报, 2018, 15(16): 130-133.
    高存友, 郭本玉, 孔素丽, 等. 晚发抑郁症患者情绪面孔持续注意偏向的瞳孔监测研究[J]. 临床精神医学杂志, 2018, 28(5): 293-296.
    戎笛声, 位照国, 杨颖佳, 等. 童年期创伤对艾司西酞普兰治疗成年抑郁症疗效的影响[J]. 中华行为医学与脑科学杂志, 2018(10): 896-900.
    Marszalek J, Price L L, Harvey W F, et al. Outcome expectations and osteoarthritis: association of perceived benefits of exercise with self-efficacy and depression[J]. Arthritis Care Res(Hoboken), 2017, 69(4): 491-498.
    杨华, 聂艳, 宁若辰. 草酸艾司西酞普兰联合rTMS治疗脑梗死后抑郁的疗效及对神经功能的影响[J]. 中国医院药学杂志, 2019, 39(15): 1578-1581.
    赵小玲, 郭文涛, 代凤琴. 不同剂量米氮平联合草酸艾司西酞普兰片治疗抑郁伴焦虑的疗效分析[J]. 中国全科医学, 2017, 20(S1): 234-236.
    符少剑, 姚乾坤, 卓东炳, 等. 度洛西汀肠溶胶囊联合艾司西酞普兰片治疗老年躯体形式障碍的临床研究[J]. 中国临床药理学杂志, 2019, 35(22): 2840-2843.
    景兰. 奥氮平联合艾司西酞普兰治疗难治性强迫症的疗效分析[J]. 安徽医药, 2018, 22(12): 2420-2423.
    屠海玲, 陈国强, 王丽平. 吡贝地尔联合艾司西酞普兰对帕金森患者运动功能及认知功能的影响[J]. 河北医药, 2017, 39(2): 201-203

    , 207.
    丁玲. 氨磺必利联合无抽搐电休克治疗难治性精神分裂症的临床疗效及安全性[J]. 中国医药指南, 2017, 15(17): 95-96.
    刘姜慧, 赵晶. 艾司西酞普兰与帕罗西汀治疗老年性抑郁症对照观察[J]. 中国民康医学, 2019, 31(17): 90-91.
    江永美, 潘小明, 王慧玲, 等. 柴胡舒肝丸辅助艾司西肽普兰治疗老年女性脑卒中后抑郁症的临床疗效研究[J]. 实用药物与临床, 2019, 22(3): 299-302.
    谭云龙, 陆峥, 石川, 等. 氨磺必利片治疗精神分裂症急性发作患者的疗效与安全性研究[J]. 中华精神科杂志, 2018, 51(2): 113-117.
    曹青. 草酸艾司西酞普兰合喹硫平治疗广泛性焦虑障碍的临床效果[J]. 实用中西医结合临床, 2019, 19(4): 110-111.
    杨华, 聂艳, 宁若辰. 草酸艾司西酞普兰联合rTMS治疗脑梗死后抑郁的疗效及对神经功能的影响[J]. 中国医院药学杂志, 2019, 39(15): 1578-1581.
    赵彤, 黄光彪, 高晓磊, 等. 不同剂量氨磺必利或利培酮对正常大鼠认知功能的影响[J]. 临床精神医学杂志, 2018, 28(3): 165-167.
    殷雪婧, 王丹阳. 艾司西酞普兰对抑郁伴ACS老年患者的临床效果[J]. 中国卫生标准管理, 2019, 10(17): 104-106.
    程宇琪, 余红军, 卢瑾, 等. 抑郁症患者艾司西酞普兰治疗八周后扣带回功能连接的变化[J]. 中华精神科杂志, 2017, 50(3): 201-207.
  • Related Articles

    [1]PENG Shunxian, TAO Hua, CHEN Xiaofeng, PENG Jifang, JIANG Shudi. Application value of C-reactive protein to albumin ratio combined with grip strength and serum prealbumin in patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(17): 15-19, 26. DOI: 10.7619/jcmp.20242187
    [2]GAO Jianying, CAO Wenjuan, GAO Yuan. Values of D-dimer, prealbumin and soluble triggering receptor expressed on myeloid cells-1 in diagnosing severe pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 108-112. DOI: 10.7619/jcmp.20223481
    [3]SHI Fang. Values of serum amyloid A and ratio of C reactive protein to prealbumin in diagnosis of acute exacerbation of chronic obstructive pulmonary disease complicated with lower respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 22-25. DOI: 10.7619/jcmp.202019007
    [4]LIU Xia. Effect of preventive nursing intervention on the incidence of hypostatic pneumonia in long term bedridden patients[J]. Journal of Clinical Medicine in Practice, 2016, (18): 32-34,38. DOI: 10.7619/jcmp.201618011
    [5]WANG Meilan. Significance of serum procalcitonin and prealbumin detections in the diagnosis of children with febrile diseases[J]. Journal of Clinical Medicine in Practice, 2015, (1): 89-91,104. DOI: 10.7619/jcmp.201501027
    [6]LI Yonghong. Value of serum CRP and PA levels in diagnosis and treatment of neonatal infections[J]. Journal of Clinical Medicine in Practice, 2014, (13): 63-65. DOI: 10.7619/jcmp.201413020
    [7]LENG Hongchun. Role of C reactive protein, prealbumin and white blood cell count and classification in differential diagnosis of children with infantile acute upper respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2014, (1): 49-52. DOI: 10.7619/jcmp.201401015
    [8]JU Jian-ping. Changes and clinical significance of serum prealbumin and C- reactive protein in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2012, (1): 97-98,101. DOI: 10.3969/j.issn.1672-2353.2012.01.033
    [9]PENG Qiao-lin. Relationship between the levels of serum prealbumin and the blood glucose control status in type 2 diabetic patients[J]. Journal of Clinical Medicine in Practice, 2011, (14): 41-42. DOI: 10.3969/j.issn.1672-2353.2011.14.017
    [10]WANG Da-ming, ZHU Bin, WANG Song-chuan. THE THERAPEUTIC EFFECTS OF CONTINUOUS RENAL REPLACEMENT THERAPY(CRRT) TO C-reactive PROTEIN(CRP) AND PREALBUMIN(PA) IN THE TREATMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME(MODS)[J]. Journal of Clinical Medicine in Practice, 2005, (8): 11-13. DOI: 10.3969/j.issn.1672-2353.2005.08.004

Catalog

    Article views (1231) PDF downloads (67) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return